Why the study?
Melatonin is involved in cardiovascular function, but its mechanism in regulating vascular permeability required investigation.
Key points are not available for this paper at this time.
Population
Human umbilical vein endothelial cells (HUVECs)
Comparison
Melatonin and pathway inhibitors vs growth factor (VEGF and EGF) stimulation
Design
In vitro laboratory study
Answers are grounded in this paper and cite their sources.
Melatonin may modulate endothelial barrier function; leaves open any clinical role in vascular permeability disorders.
Melatonin is a natural hormone involved in the regulation of circadian rhythm, immunity, and cardiovascular function. In the present study, we focused on the mechanism of melatonin in the regulation of vascular permeability. We found that melatonin could inhibit both VEGF- and EGF-induced monolayer permeability of human umbilical vein endothelial cells (HUVECs) and change the tyrosine phosphorylation of vascular-endothelial (VE-)cadherin, which was related to endothelial barrier function. In addition, phospho-AKT (Ser 473 ) and phospho-ERK(1/2) played significant roles in the regulation of VE-cadherin phosphorylation. Both the phosphatidylinositol 3-kinase/AKT inhibitor LY49002 and MEK/ERK inhibitor U0126 could inhibit the permeability of HUVECs, but with different effects on tyrosine phosphorylation of VE-cadherin. Melatonin can influence the two growth factor-induced phosphorylation of AKT (Ser 473 ) but not ERK(1/2). Our results show that melatonin can inhibit growth factor-induced monolayer permeability of HUVECs by influencing the phosphorylation of AKT and VE-cadherin. Melatonin can be a potential treatment for diseases associated with abnormal vascular permeability. NEW & NOTEWORTHY We found that melatonin could inhibit both EGF- and VEGF-induced monolayer permeability of human umbilical vein endothelial cells, which is related to phosphorylation of vascular-endothelial cadherin. Blockade of phosphatidylinositol 3-kinase/AKT and MEK/ERK pathways could inhibit the permeability of human umbilical vein endothelial cells, and phosphorylation of AKT (Ser 473 ) might be a critical event in the changing of monolayer permeability and likely has cross-talk with the MEK/ERK pathway.
No takes yet. Share an insight, caveat, or question.
Ling et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: